Objectives: The clinical utility of complementary tests for brucellosis are not clear in many situation. This study aimed to evaluate value of these tests for brucellosis in an endemic area in Turkey.
INTRODUCTION
Brucellosis is a zoonotic disease caused by the bacteria genus Brucella and it is encountered in animals, such as sheep, cows, and goats, as well as humans. The onset of human brucellosis may be acute or insidious, and the clinical manifestations are protean. The disease is generalized and it may involve any organ or system of the body. Presenting complaints are numerous and nonspecific, including malaise, anorexia, fatigue, sweats, weight loss, back or joint pains, and depression. Objective physical findings are few, notably fever, mild lymphadenopathy, and, occasionally, hepatomegaly or splenomegaly. 1 The clinical features are non-specific and can overlap with a wide spectrum of other infectious and non-infectious diseases. To reach a diagnosis, clinicians must use a wide range of non-specific routine hematological and biochemical tests in addition to Brucella-specific assays. The latter are microbiological (culture), serological (e.g., slide or tube agglutination, Coombs test, immunocapture-agglutination, BrucellaCapt test, immunochromatographic lateral flow, enzymelinked immunosorbent assays, and the indirect fluorescent antibody test), and molecular (e.g., polymerase chain reaction (PCR) and real-time PCR). Each of these tests has advantages and limitations and, thus, requires careful interpretation.
The isolation of the organism from blood samples or other clinical specimens (e.g., spinal fluid, bone marrow, or tissue cultures) is the golden standard for brucellosis diagnosis. However, Brucella is a slow growing organism and depending on illness stage, it may not be cultivatable. 2 Therefore, diagnosis is often made by serological tests.
The Rose Bengal (RB) test is a simple screening test but may give false positive results in endemic areas. The standard serum agglutination test (SAT) is used in endemic areas for this reason. 3, 4 This test can detect both IgM and IgG and, consequently, can be helpful in diagnosing acute, relapsing, and chronic infection. However, the SAT is relatively complicated, time consuming, and requires qualified personals to perform. For this reason, some immunochromatographic assays were developed for the detection of Brucella-specific IgG and IgM antibodies.
5
A negative reaction in the SAT will not exclude active infection as the infection may be in the incubation period in which the patient has not yet produced detectable antibodies against the organism. The prozone phenomenon also results in a negative reaction; this can be prevented by using serial dilutions of the serum. A positive reaction with a given antigen may not be diagnostic, as the patient may exhibit a rise in heterologous agglutinins during the course of the illness. Such reactions are known as nonspecific anamnestic reactions because the patient has responded to an antigenic stimulus with production of nonspecific agglutinins. This makes serological diagnosis based on a single high antibody titer too uncertain, and only seroconversion with a fourfold or greater rise in titer on serial dilutions of sera should be accepted as an indication of a recent infection.
Most patients with acute brucellosis will have an agglutinin titer of 1/320 or greater by the end of the second week of illness. Even one year after treatment, 20% of patients will continue to have a significant Brucella agglutinin titer. High Brucella agglutinin titers have also been recorded in patients with Francisella tularensis and Yersinia enterocolitica infections and in patients who have recently had a cholera vaccination or been tested with a brucellergin skin test. They have also occasionally been recorded in abattoir workers.
Patients with localized brucellosis may be afebrile and may not have significant levels of Brucella agglutinin titer. In these cases, the infection should be suspected on epidemiological grounds and by detection of calcified lymph nodes on Xray, but the diagnosis should be confirmed by culture. The RB test is a screening test designed to detect agglutinins, whereas the SAT is a confirmatory test designed to measure the agglutinin quantitatively. relapsed, active, and inactive), the search for reliable, discriminatory diagnostic and prognostic markers, especially for monitoring disease evaluation, are ongoing. In this study we aimed to determine negative and positive predictivite values for these serological tests to help general practitioners working in endemic area.
MATERIALS AND METHODS
Canakkale province is located at north-west region of Turkey with about 450.000 populations.
The most important income for city region is dairy products (especially cheese). An important part of the cheese production made by traditional methods in little dairy farm corporations. Canakkale State Hospital is the only hospital provides secondary care facility to region.
Patients and Clinical Specimens: Totally 131 adult patient admitted to Infectious Diseases Clinic of Canakkale State Hospital between JanDecember 2009 were evaluated in this study. Patients ranges between 19-68 years (mean: 41,71±12,49) and 74 female, 57 male. All patients had no history of brucellosis and onset of symptoms was less than 3 months.
The diagnosis of brucellosis was based on clinical findings (fever, sweating, muscle weakness, arthralgia, appetite loss and weight loss), positivity of blood cultures for Brucella or a Standard serum agglutination test titter of ≥ 1/160 and at least fourfold rise of titter in 15 days period. Differential diagnosis for tuberculosis, yersinosis, salmonellosis, tularemia, were all ruled out by serological tests for pathogens following standard microbiological procedures. Blood cultures were performed from hospitalized 43 acute brucellosis cases but only 9 isolate is cultivated. Twenty millimeters blood samples were obtained and extracted seras frozen at -20°C until processing for serological studies. Totally 105 sera samples from healthy individuals (blood donors) were taken and used as control group. This group consist of 43 female and 62 male, ranged between 18-59 years (mean: 40,34±9,82).
Serological and bacteriological methods
The Rose Bengal test was performed with commercial Brucella abortus antigen (Refik Saydam Laboratories, Ankara, Turkey), according to manufacturer's instructions. Titrations were made by serial twofold dilutions with saline solution. Standard serum agglutination test (SAT) was performed as described by Kerr et al. 7 Standard commercial Brucella abortus antigen was used (Refik Saydam Laboratories, Ankara, Turkey). Serum titrations was started from 1/40 titters and dilated as twofold titrations until 1/5160 by saline solution. Coombs test was performed as described by Kerr et al. 7 Titters was made as SAT and after centrifugation of seras, tubes were washed tree times by using 3% saline solution. After that one drop Coombs sera (Refik Saydam Laboratories, Ankara, Turkey) was added and inoculated at 37°C for 24 hours before samples read. The Brucellacapt test (Vircell SL, Granada, Spain) was performed as specified by the manufacturer. Brucella IgG and IgM ELISAs were performed using a commercial kit test (Vircell SL, Granada, Spain). The testing procedure was followed as manufacturer's instructions. Titters over 30U for IgG and over 20U for IgM were considered positive by the manufacturer. Blood cultures were processed in automated system (VERSA-TREK™, USA). If no growth was detected within five day, incubation was maintained for 30 days and blind subcultures were plated on Brucella agar (Beckton Dickinson, USA) after 7 days repeatedly. Subcultures were incubated at 37°C in 5-10% CO 2 atmosphere for three days. If growth appeared, the suspected colonies were identified by morphology, Gram staining, oxidase, catalase, urease tests and positive agglutination with specific antiserum. Bacteria serotyping was not performed.
Statistical analysis: Sensitivity, specificity and positive and negative predictive values were calculated. Statistical analysis was made by using SPSS10.0 for Windows statistical package programme. For SAT and Coombs titters, cut-off point is accepted as 1/160 as many textbooks advised. 1,6,8 In patient group seropositivity was found as 37,40% (49/131) and seronegativity was 62,59% (82/131). Seropositivity for control group was found as 0,95% (1/105) and seronegativity was 99,05% (104/105).
RESULTS

Totally
For Coombs tests seropositivity for patient group was found as 72,51% (95/131) and seronegativity was 27,49% (36/131). In control group no seropositivity was found, all the sera were seronegative.
When BrucellaCapt evaluated, most of authors advises 1/320 titter for cut-off value. 6, 8 Seropositivity for patient group was found as 74,04% (97/131) and seronegativity was 25,96% (34/131). If the cut-off titter accepted as 1/160 seropositivity would be found as 80,91% (106/131). By this method no seropositivity found in control group and all sera samples were seronegative (Table 1) .
Totally 236 sera samples were evaluated for Brucella seropositivity by ELISA IgG and IgM assays. Therefore all samples evaluated for both IgG and IgM seropositivity too. In patient group seropositivity rate was found as 65,64% (86/131) with IgG kit and 49,61% (65/131) with IgM kit. Seronegativitiy rate was found as 34,36% (45/131) with IgG kit and 50,38% (66/131) with IgM kit. In control group seropositivity was only 0,95% (1/105) with IgG and no seropositivity was found with IgM kit in that group. When both results evaluated for IgG+IgM, in patient group seropositivity was found as 34,35% (45/131) and seronegativity was 65,65% (86/131) eventually (Table 2) .
Statistically in six test (RB, SAT, Coombs, B.Capt, ELISA IgG and IgM) p values were performed by Chi Square test with SPSS 10.0 and seropositivity differences were found meaningful between patient and control groups (p≤ 0,05). The sensitivity, specificity, positive and negative predictive values (PPV and NPV) was calculated as seen on Table 4 summarizes results for culture-positive patients. It has been found that all culture positive patients yielded seropositivity for brucellosis.
After than ROC analysis was performed for all six brucella serological tests (Graphic1-2). As seen on graphic 1 the area under curve is most valuable for Coombs test (0,9251) so we found this test most reliable for brucellosis diagnosis. By the way BrucellaCapt test was found as powerful as Coombs test (area under curve: 0,9472). Surprisingly Rose Bengal test was found more reliable than SAT (area under curve: 0,8365 and 0,8263 eventually). 
DISCUSSION
Brucellosis is an endemic disease for animal and human population in Turkey. In eastern part of country seroprevalance in human was found 11,9% by Rose Bengal test and 5,4% by SAT. 9 It has been found in another study that brucella seropositivity is 32,92% by SAT and 39,45% by ELISA in bovine sera samples from eastern part of Turkey. 10 In western part of Turkey which Canakkale province located at, brucella seroprevalance was found 4,8-8,5% by Rose Bengal test and 2,9-5,6% by SAT in non-symptomatic healthy population. 11, 12 Recently in a study from eastern part of Turkey diagnostic values for brucellosis was evaluated in symptomatic patient group. 13 In that study specificity for SAT, ELISA IgG, ELISA IgM was found as 100%, 95% and 75% eventually. Positive predictive value for SAT was found 100%, for ELISA IgG 96,3% and 90,9% for ELISA IgM. This values states that positive results are very powerful clues for diagnosis of Brucella serodiagnosis. On the contrary, a negative predictive value for SAT was found 90,9% for ELISA IgM 89,5% and for ELISA IgG 76,0% which means that negative serological tests can't exclude brucellosis diagnosis.
Symptomatic patient group Brucella IgG seropositivity was found 87,35% and IgM seropositivity 36,78% in a study performed in central-Anatolian part of Turkey. 14 The sensitivities of Brucellosis tests were found 92% for SAT, 98% for ELISA IgG and 100% for ELISA IGM in another study from Kuwait. 15 Blood cultures have been found positive for only 53% of patients in that study.
In a study from Spain which is epidemic region for brucellosis, the sensitivity value for SAT was found as 65,8%, for Coombs test as 91,5% and for BrucellaCapt as 95,1% 16 In onether study from same region the sensitivity and specificity values for Rose Bengal, SAT, Coombs Test and Brucellacapt was found over 90% whereas IgM and IgG ELISAs have the lowest sensitivity (60% and 84%, respectively). 17 In our study six test for evaluated for serological diagnosis of brucellosis. All tests were found valuable for positive results but only Brucella Coombs test and BrucellaCapt were found reliable for negative serological results. Brucella ELISA IgG and IgM tests were found no superior to others.
Accurate diagnosis of brucellosis in human may be very difficult in some cases. The 'gold standard', is the recovery of the causative agent from the host. Molecular biology as a diagnostic tool is advancing and will soon be at the point 
